STOCK TITAN
  1. Home
  2. Sec-filings
  3. ASTH
  4. [Form 4] Astrana Health, Inc. Insider Trading Activity

Astrana Health (ASTH) CFO surrenders shares to cover tax on vesting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Astrana Health, Inc. COO and CFO Basho Chandan surrendered 3,870 shares of common stock at $29.07 per share on April 14, 2026 to cover tax withholding obligations on newly vested restricted stock. After this tax-withholding disposition, he directly holds 167,765 shares, including 30,404 unvested restricted shares and additional restricted stock units scheduled to vest through 2027.

Positive

  • None.

Negative

  • None.
Insider Basho Chandan
Role COO and CFO
Type Security Shares Price Value
Tax Withholding Common Stock 3,870 $29.07 $113K
Holdings After Transaction: Common Stock — 167,765 shares (Direct)
Footnotes (1)
  1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026. Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Shares surrendered for tax 3,870 shares Tax-withholding disposition on April 14, 2026
Price per surrendered share $29.07 per share Value used for tax-withholding disposition
Shares held after transaction 167,765 shares Direct common stock holdings following disposition
Unvested restricted stock 30,404 shares Will vest in two equal annual installments in 2026 and 2027
RSUs vesting from Oct 2026 15,604 units Vest in four equal semi-annual installments beginning October 2, 2026
RSUs vesting from Sep 2026 20,027 units Vest in six equal semi-annual installments beginning September 5, 2026
tax withholding obligations financial
"Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock"
restricted stock financial
"associated with certain shares of restricted stock that vested on April 14, 2026"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
unvested restricted stock financial
"Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments"
restricted stock units financial
"Also includes the following restricted stock units, which will vest as follows"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
semi-annual installments financial
"restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Basho Chandan
(Last)(First)(Middle)
C/O ASTRANA HEALTH, INC.
1668 S. GARFIELD AVENUE, 2ND FLOOR
(Street)
ALHAMBRA CALIFORNIA 91801
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
COO and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/14/2026F3,870(1)D$29.07167,765(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026.
2. Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
/s/ Kathy Diep, as Attorney-in-Fact04/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Astrana Health (ASTH) executive Basho Chandan report in this Form 4?

Basho Chandan reported surrendering 3,870 Astrana Health common shares to cover tax withholding on vested restricted stock. This was a non-market transaction coded as tax-withholding, leaving him with 167,765 directly held shares plus additional unvested restricted stock and restricted stock units.

Was the Astrana Health (ASTH) Form 4 transaction a market sale of shares?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were surrendered back to offset tax obligations arising from restricted stock that vested on April 14, 2026, a common administrative step when equity awards vest for executives.

How many Astrana Health (ASTH) shares does Basho Chandan hold after this Form 4?

After the tax-withholding disposition, Basho Chandan directly holds 167,765 Astrana Health common shares. This total includes vested shares and 30,404 unvested restricted shares, along with additional restricted stock units scheduled to vest in semi-annual installments through 2027, subject to continued employment.

What future vesting schedule is disclosed for Astrana Health (ASTH) restricted stock and RSUs?

The filing notes 30,404 unvested restricted shares vesting in two equal annual installments on May 16, 2026 and 2027. It also lists 15,604 restricted stock units vesting in four equal semi-annual installments from October 2, 2026 and 20,027 units vesting in six installments from September 5, 2026.

What does the Form 4 tax-withholding code mean for Astrana Health (ASTH) insiders?

The tax-withholding code indicates shares were surrendered to satisfy tax obligations when equity awards vest, rather than sold in the market. For Astrana Health insiders, this reflects an administrative disposition used to cover taxes due, without an open-market trading decision.